NYSE ORDER IMBALANCE 263852.0 SHARES ON BUY SIDE
15/07/2022 20:50
NYSE ORDER IMBALANCE ADCT.N 263852.0 SHARES ON BUY SIDE
Recent news on Adc Therapeutics
See all newsBrief: Adc Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
ADC Therapeutics SA reports results for the quarter ended June 30 - Earnings Summary
ADC Therapeutics Q2 loss narrows; cuts 17% workforce
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview